GSK will buy Bel­lus Health for $2B, set­ting up show­down with Mer­ck

GSK is dish­ing out $2 bil­lion to ac­quire Bel­lus Health, the British phar­ma gi­ant an­nounced Tues­day morn­ing, stok­ing more M&A buzz amid a wide­spread …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA